Molecular and Biological Functions of Melatonin in Endometrial Cancer-Reference-Cited by-同舟云学术

Molecular and Biological Functions of Melatonin in Endometrial Cancer

Published:2020-04-20 Issue:5 Volume:21 Page:519-526
ISSN:1389-4501
Container-title:Current Drug Targets
language:en
Short-container-title:CDT

Author:

Dana Parisa Maleki¹,Sadoughi Fatemeh¹,Mobini Moein²,Shafabakhsh Rana¹,Chaichian Shala³,Moazzami Bahram³,Chamani Maryam⁴,Asemi Zatollah¹

Affiliation:

1. Research Center for Biochemistry and Nutrition in Metabolic Diseases, Kashan University of Medical Sciences, Kashan, Iran

2. Faculty of Kinesiology, University of Calgary, Calgary, AB, Canada

3. Pars Advanced and Minimally Invasive Medical Manners Research Center, Pars Hospital, Iran University of Medical Sciences, Tehran, Iran

4. Department of Gynecology and Obstetrics, School of Medicine, Iran University of Medical Sciences, Tehran, Iran

Abstract

Endometrial cancer is the fifth leading cancer among women. This rate is higher in developed countries and its incidence is increasing worldwide. Diabetes mellitus, obesity, hypertension and arteriosclerosis are major risk factors for endometrial cancer. Melatonin is a hormone synthesized in the pineal and extra-pineal organs such as the digestive tract, bone marrow, retina and more. Evidence shows the potential effects of melatonin in endometrial cancer inhibition. Therefore, the focus of this paper is to review this outstanding evidence and to summarize the molecular and biological mechanisms of melatonin for the inhibition of endometrial cancer.

Publisher

Bentham Science Publishers Ltd.

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine

Reference100 articles.

1. Jemal A.; Bray F.; Center M.M.; Ferlay J.; Ward E.; Forman D.; Global cancer statistics. CA Cancer J Clin 2011,61(2),69-90

2. Purdie D.M.; Green A.C.; Epidemiology of endometrial cancer. Best Pract Res Clin Obstet Gynaecol 2001,15(3),341-354

3. Amant F.; Moerman P.; Neven P.; Timmerman D.; Van Limbergen E.; Vergote I.; Endometrial cancer. Lancet 2005,366(9484),491-505

4. Clark T.J.; Mann C.H.; Shah N.; Khan K.S.; Song F.; Gupta J.K.; Accuracy of outpatient endometrial biopsy in the diagnosis of endometrial cancer: a systematic quantitative review. BJOG 2002,109(3),313-321

5. Dijkhuizen F.P.; Mol B.W.; Brölmann H.A.; Heintz A.P.; The accuracy of endometrial sampling in the diagnosis of patients with endometrial carcinoma and hyperplasia: a meta-analysis. Cancer 2000,89(8),1765-1772

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of significant biomarkers for predicting the risk of bipolar disorder with arteriosclerosis based on integrative bioinformatics and machine learning;Frontiers in Psychiatry;2024-09-03

2. Melatonin suppresses tumor proliferation and metastasis by targeting GATA2 in endometrial cancer;Journal of Pineal Research;2023-10-09

3. Melatonin enhances the sensitivity of colorectal cancer cells to 5‐fluorouracil through the regulation of the miR‐532‐3p/β‐catenin pathway;Environmental Toxicology;2023-09-26

4. A novel poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV)-PEG-melatonin composite scaffold enhances for inhibiting bone tumor recurrence and enhancing bone regeneration;Frontiers in Pharmacology;2023-08-17

5. Codelivery of resveratrol melatonin utilizing pH responsive sericin based nanocarriers inhibits the proliferation of breast cancer cell line at the different pH;Scientific Reports;2023-07-08